| 中文名称 | N-氧代烟酰胺 |
| 英文名称 | Nicotinamide-N-oxide |
| CAS号 | 1986-81-8 |
| 分子式 | C6H6N2O2 |
| 分子量 | 138.12 |
| EINECS号 | 217-859-4 |
| 熔点 | 291-293 °C (dec.)(lit.) |
| 沸点 | 253.51°C (rough estimate) |
| 密度 | 1.3471 (rough estimate) |
| 折射率 | 1.5100 (estimate) |
| 溶解度 | 可溶于DMSO(略微加热)、甲醇(略微加热) |
| 形态 | 固体 |
| 酸度系数(pKa) | 14.38±0.50(Predicted) |
| 颜色 | 白色至类白色 |
| 敏感性 | Hygroscopic |
| 危险品标志 | Xi |
| 危险类别码 | 36/37/38 |
| 安全说明 | 26-36 |
| WGK Germany | 3 |
| 海关编码 | 29339900 |
|
CXCR2
|
Human Endogenous Metabolite
|
Nicotinamide is one of the forms of vitamin B 3 . It is a precursor for nicotinamide adenine dinucleotide, which is best known as an electron carrier in oxidative phosphorylation and as a cofactor for many dehydrogenases. It is metabolized through two enzymatic systems. The first system starts with the methylation of nicotinamide by nicotinamide N-methyltransferase, which can subsequently be oxidized by aldehyde oxidase. The second enzymatic system oxidizes nicotinamide to nicotinamide N-oxide. A series of nicotinamide N-oxides is synthesized and shown to be novel, potent, and selective antagonists of the CXCR2 receptor. Compound 1 has demonstrated potent inhibition of neutrophil chemotaxis (IC 50 =10 nM). Compound 2 is a selective antagonist of IL-8 binding (IC 50 =110 nM) and potent inhibitor of neutrophil chemotaxis (IC 50 =170 nM).